Hypertension and CKD

Advances in Chronic Kidney Disease

Volumn 18, Issue 5, 2011, Pages 355-361

  VanDeVoorde, Rene G ^a   Mitsnefes, Mark M ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Children; Chronic kidney disease; Hypertension

Indexed keywords

AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARVEDILOL; CLONIDINE; DIHYDROPYRIDINE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDRALAZINE; METOPROLOL; MINOXIDIL; NIFEDIPINE; PRAZOSIN; THIAZIDE DIURETIC AGENT; VERAPAMIL;

ADD ON THERAPY; ATHEROSCLEROSIS; BLOOD PRESSURE MONITORING; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CHILD CARE; CHRONIC KIDNEY DISEASE; CHRONIC KIDNEY FAILURE; COMORBIDITY; DISEASE COURSE; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; KIDNEY DISEASE; KIDNEY FAILURE; PEDIATRICS; PREVALENCE; PRIORITY JOURNAL; REVIEW;

ANTIHYPERTENSIVE AGENTS; ATHEROSCLEROSIS; CARDIOMYOPATHIES; CLINICAL TRIALS AS TOPIC; DISEASE PROGRESSION; FEMALE; HUMANS; HYPERTENSION; MALE; PREVALENCE; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 80052404799     PISSN: 15485595     EISSN: 15485609     Source Type: Journal    
DOI: 10.1053/j.ackd.2011.03.003     Document Type: Review

References (57)

1. Muntner P., He J., Astor B.C., Folsom A.R., Coresh J. Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: results from the atherosclerosis risk in communities study. J Am Soc Nephrol 2005, 16:529-538.
2. Go A.S., Chertow G.M., Fan D., McCulloch C.E., Hsu C.Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004, 351:1296-1305.
3. North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) 2008 Annual Report 2008, The EMMES Corporation, Rockville, MD.
4. Mitsnefes M., Ho P.L., McEnery P.T. Hypertension and progression of chronic renal insufficiency in children: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). J Am Soc Nephrol 2003, 14:2618-2622.
5. Flynn J.T., Mitsnefes M., Pierce C., et al. Blood pressure in children with chronic kidney disease: a report from the Chronic Kidney Disease in Children study. Hypertension 2008, 52:631-637.
6. Chavers B.M., Solid C.A., Daniels F.X., et al. Hypertension in pediatric long-term hemodialysis patients in the United States. Clin J Am Soc Nephrol 2009, 4:1363-1369.
7. Muntner P., Anderson A., Charleston J., et al. Hypertension awareness, treatment, and control in adults with CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis 2009, 55:441-451.
8. Fivush B.A., Jabs K., Neu A.M., et al. Chronic renal insufficiency in children and adolescents: the 1996 annual report of NAPRTCS. Pediatr Nephol 1998, 12:328-337.
9. Schaefer F. Hypertension in chronic kidney disease. Pediatric Hypertension 2011, 397-418. Humana Press, New York, NY. 2nd ed. J.T. Flynn, J.R. Ingelfinger, R.J. Portman (Eds.).
10. K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis 2004, 43(5 suppl. 1):S1-S290.
11. Dionne J.M., Turik M.M., Hurley R.M. Blood pressure abnormalities in children with chronic kidney disease. Blood Press Monit 2008, 13:205-209.
12. Mitsnefes M.M., Kimball T.R., Daniels S.R. Office and ambulatory blood pressure elevation in children with chronic renal failure. Pediatr Nephrol 2003, 18:145-149.
13. Mitsnefes M., Flynn J., Cohn S., et al. Masked hypertension associates with left ventricular hypertrophy in children with CKD. J Am Soc Nephrol 2010, 21:137-144.
14. Andersen M.J., Khawandi W., Agarwal R. Home blood pressure monitoring in CKD. Am J Kidney Dis 2005, 45:994-1001.
15. Hadtstein C., Schaefer F. Hypertension in children with chronic kidney disease: pathophysiology and management. Pediatr Nephrol 2008, 23:363-371.
16. Tkaczyk M., Nowicki M., Balasz-Chmielewska I., et al. Hypertension in dialysed children: the prevalence and therapeutic approach in Poland-a nationwide survey. Nephrol Dial Transplant 2006, 21:736-742.
17. VanDeVoorde R.G., Barletta G.M., Chand D.H., et al. Blood pressure control in pediatric hemodialysis: the Midwest Pediatric Nephrology Consortium Study. Pediatr Nephrol 2007, 22:547-553.
18. Vaziri N.D., Ni Z., Wang X.Q., Oveisi F., Zhou X.J. Downregulation of nitric oxide synthase in chronic renal insufficiency: role of excess PTH. Am J Physiol 1998, 274(4 Pt 2):F642-F649.
19. Querfeld U., Anarat A., Bayazit A.K., et al. The cardiovascular comorbidity in children with chronic kidney disease (4C) study: objectives, design, and methodology. Clin J Am Soc Nephrol 2010, 5:1642-1648.
20. Port R.E., Kiepe D., Van Guilder M., Jelliffe R.W., Mehls O. Recombinant human erythropoietin for the treatment of renal anaemia in children: no justification for bodyweight-adjusted dosage. Clin Pharmacokinet 2004, 43:57-70.
21. Tonshoff B., Heinrich U., Mehls O. How safe is the treatment of uraemic children with recombinant human growth hormone?. Pediatr Nephrol 1991, 5:454-460.
22. Peterson J.C., Adler S., Burkart J.M., et al. Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann Intern Med 1995, 123:754-762.
23. Klag M.J., Whelton P.K., Randall B.L., et al. Blood pressure and end-stage renal disease in men. N Engl J Med 1996, 334:13-18.
24. Bakris G.L., Williams M., Dworkin L., et al. Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am J Kidney Dis 2000, 36:646-661.
25. Chobanian A.V., Bakris G.L., Black H.R., et al. The Seventh Report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003, 289:2560-2572.
26. Mancia G., De Backer G., Dominiczak A., et al. 2007 Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007, 25:1105-1187.
27. Wingen A.M., Fabian-Bach C., Schaefer F., Mehls O. Randomised multicentre study of a low-protein diet on the progression of chronic renal failure in children. European Study Group of Nutritional Treatment of Chronic Renal Failure in Childhood. Lancet 1997, 349:1117-1123.
28. Wuhl E., Trivelli A., Picca S., et al. Strict blood-pressure control and progression of renal failure in children. N Engl J Med 2009, 361:1639-1650.
29. Berl T., Hunsicker L.G., Lewis J.B., et al. Impact of achieved blood pressure on cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial. J Am Soc Nephrol 2005, 16:2170-2179.
30. Wright J.T., Bakris G., Greene T., et al. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA 2002, 288:2421-2431.
31. Appel L.J., Wright J.T., Greene T., et al. Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med 2010, 363:918-929.
32. Lewis J.B. Blood pressure control in chronic kidney disease: is less really more?. J Am Soc Nephrol 2010, 21:1086-1092.
33. Kovesdy C.P., Trivedi B.K., Kalantar-Zadeh K., Anderson J.E. Association of low blood pressure with increased mortality in patients with moderate to severe chronic kidney disease. Nephrol Dial Transplant 2006, 21:1257-1262.
34. Chavers B.M., Li S., Collins A.J., Herzog C.A. Cardiovascular disease in pediatric chronic dialysis patients. Kidney Int 2002, 62:648-653.
35. Gosse P. Left ventricular hypertrophy as a predictor of cardiovascular risk. J Hypertens Suppl 2005, 23:S27-S33.
36. Johnstone L.M., Jones C.L., Grigg L.E., Wilkinson J.L., Walker R.G., Powell H.R. Left ventricular abnormalities in children, adolescents and young adults with renal disease. Kidney Int 1996, 50:998-1006.
37. Mitsnefes M.M., Kimball T.R., Witt S.A., Glascock B.J., Khoury P.R., Daniels S.R. Left ventricular mass and systolic performance in pediatric patients with chronic renal failure. Circulation 2003, 107:864-868.
38. Matteucci M.C., Wuhl E., Picca S., et al. Left ventricular geometry in children with mild to moderate chronic renal insufficiency. J Am Soc Nephrol 2006, 17:218-226.
39. Mitsnefes M.M., Kimball T.R., Kartal J., et al. Progression of left ventricular hypertrophy in children with early chronic kidney disease: 2-year follow-up study. J Pediatr 2006, 149:671-675.
40. Mancia G., Parati G. The role of blood pressure variability in end-organ damage. J Hypertens Suppl 2003, 21:S17-S23.
41. Litwin M., Wuhl E., Jourdan C., et al. Altered morphologic properties of large arteries in children with chronic renal failure and after renal transplantation. J Am Soc Nephrol 2005, 16:1494-1500.
42. Poyrazoglu H.M., Dusunsel R., Yikilmaz A., et al. Carotid artery thickness in children and young adults with end stage renal disease. Pediatr Nephrol 2007, 22:109-116.
43. Mitsnefes M.M., Kimball T.R., Witt S.A., Glascock B.J., Khoury P.R., Daniels S.R. Abnormal carotid artery structure and function in children and adolescents with successful renal transplantation. Circulation 2004, 110:97-101.
44. Krmar R.T., Balzano R., Jogestrand T., Cedazo-Minguez A., Englund M.S., Berg U.B. Prospective analysis of carotid arterial wall structure in pediatric renal transplants with ambulatory normotension and in treated hypertensive recipients. Pediatr Transplant 2008, 12:412-419.
45. Parekh R.S., Carroll C.E., Wolfe R.A., Port F.K. Cardiovascular mortality in children and young adults with end-stage kidney disease. J Pediatr 2002, 141:191-197.
46. Oh J., Wunsch R., Turzer M., et al. Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 2002, 106:100-105.
47. Groothoff J.W., Gruppen M.P., Offringa M., et al. Mortality and causes of death of end-stage renal disease in children: a Dutch cohort study. Kidney Int 2002, 61:621-629.
48. McDonald S.P., Craig J.C. Long-term survival of children with end-stage renal disease. N Engl J Med 2004, 350:2654-2662.
49. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004, 114(2 suppl. 4th report):555-576.
50. Lurbe E., Cifkova R., Cruickshank J.K., et al. Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension. J Hypertens 2009, 27:1719-1742.
51. Urbina E., Alpert B., Flynn J., et al. Ambulatory blood pressure monitoring in children and adolescents: recommendations for standard assessment: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee of the council on cardiovascular disease in the young and the council for high blood pressure research. Hypertension 2008, 52:433-451.
52. Agarwal R. Home and ambulatory blood pressure monitoring in chronic kidney disease. Curr Opin Nephrol Hypertens 2009, 18:507-512.
53. Delucchi A., Dinamarca H., Gainza H., Whitttle C., Torrealba I., Iniguez G. Carotid intima-media thickness as a cardiovascular risk marker in pediatric end-stage renal disease patients on dialysis and in renal transplantation. Transplant Proc 2008, 40:3244-3246.
54. Wuhl E., Schaefer F. Therapeutic strategies to slow chronic kidney disease progression. Pediatr Nephrol 2008, 23:705-716.
55. Griffin K.A., Bidani A.K. Calcium-channel blockers and the progression of renal disease. Curr Hypertens Rep 1999, 1:436-445.
56. Sahney S. A review of calcium channel antagonists in the treatment of pediatric hypertension. Paediatr Drugs 2006, 8:357-373.
57. Bakris G.L., Copley J.B., Vicknair N., Sadler R., Leurgans S. Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy. Kidney Int 1996, 50:1641-1650.